clindamycine
J - Antiinfectives For Systemic Use -> J01 - Antibacterials For Systemic Use -> J01F - Macrolides, Lincosamides And Streptogramins -> J01FF - Lincosamides -> J01FF01 - Clindamycin
Administration category:
Free
Medicine group:
antibacterial
Brand name:
Dalacin
Safety margins
| Weight | ROA | Dosage |
|---|---|---|
|
ROA: po |
Dosage: min. 150mg 4 dd to max. 600mg 3 dd |
|
|
ROA: iv |
Dosage: min. 150mg 4 dd to max. 900mg 3 dd |
Kidney function
Renal elimination:
10-20%
Dosage:
independent on kidney function
Interactions
| Interaction with (ATC): | Expected effect: |
|---|---|
|
Interaction with (ATC): J05AE - Protease Inhibitors |
Expected effect: verhoging plasmaconcentratie clindamycine |
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-1273.2
Updated: 09/18/2019 - 16:37
Status: Published
General comments
CVVH: geen aanpassing nodig